Genomic Valley Biotech

Genomic Valley Biotech EBIT par action

EBIT par action de Genomic Valley Biotech (539206.BO) au 16 oct. 2026 est 1,43 INR. L'année précédente, EBIT par action était 0,04 INR — une variation de 3 101,25 % (plus élevé).

EBIT par action

1,43INR

YoY

3 101,25%

Dernière mise à jour:

EBIT par action de Genomic Valley Biotech est 2025 1,43 INR. EBIT par action de Genomic Valley Biotech était 2024 0,04 INR. Elle diminue ainsi de 3 101,25% plus élevé par rapport à l'année précédente.

L'histoire de Genomic Valley Biotech EBIT par action

  • 3 ans

  • 10 ans

  • 25 ans

  • Max

EBIT par action
Date
EBIT par action
1 janv. 2022
-1,50 INR
1 janv. 2023
2,85 INR
1 janv. 2024
0,04 INR
1 janv. 2025
1,43 INR
L'histoire de Genomic Valley Biotech EBIT par action
ANNÉEEBIT par actionYoY
1,43INR+3 101,25%
0,04INR-98,43%
2,85INR-290,65%
-1,50INR—

Accéder à ces données via l’API Eulerpool

100 000 requêtes/mois gratuites · sans carte bancaire

Genomic Valley Biotech Analyse d'actions

Que fait Genomic Valley Biotech ? Genomic Valley Biotech Ltd, identified by the ticker symbol 539206.BO and the ISIN code INE574D01010, is an Indian corporate entity established within the biotechnology and life sciences sector. The company maintains its primary operational headquarters in Bahadurgarh, a city located in the state of Haryana, India. This geographical positioning places the firm within a significant industrial and technological hub in northern India, facilitating its business operations and strategic partnerships within the regional ecosystem. The organization entered the public equity markets through an Initial Public Offering that was officially executed on July 10, 2015. This milestone marked a critical transition in the company's corporate history, allowing it to raise capital from public investors and increase its visibility within the financial markets. The listing on the Bombay Stock Exchange under the specified ticker provides a mechanism for public trading and valuation of the company's shares. While specific details regarding its industry classification and sector categorization are not explicitly defined in the available reference data, the company's name and operational focus imply a specialization in genomic technologies and biotechnological solutions. The corporate profile is further accessible through its official digital presence at http://www.genomicvalley.com/, where stakeholders and interested parties can obtain additional information regarding its business activities, corporate governance, and financial performance. As a publicly traded entity, Genomic Valley Biotech Ltd is subject to the regulatory frameworks and disclosure requirements mandated by Indian securities regulators. The company's journey from its foundational establishment to its public listing in 2015 represents a structured growth trajectory aimed at expanding its reach and capabilities in the competitive biotech landscape. Investors and analysts monitoring the Indian market may track the company's performance through its stock ticker, utilizing the ISIN for precise identification in global financial databases. The lack of explicit sector or industry tags in the provided data does not diminish the company's operational identity, which remains anchored in the scientific and technological advancements associated with genomics and biotechnology. The headquarters in Bahadurgarh serves as the central node for administrative, research, and strategic decision-making processes, supporting the company's ongoing initiatives and market engagements. Genomic Valley Biotech est l'une des entreprises les plus populaires sur Eulerpool.

Questions fréquemment posées sur l'action Genomic Valley Biotech

EBIT par action de Genomic Valley Biotech s'élève à 1,43 INR en 2025.

EBIT par action de Genomic Valley Biotech a changé de 0,04 INR à 1,43 INR, ce qui représente une variation de 3 101,25 %. La valeur est plus élevé qu'l'année précédente.

Sur Eulerpool, vous trouverez l'évolution historique complète de Genomic Valley Biotech de EBIT par action depuis 2006 – avec des valeurs annuelles, des graphiques et une analyse détaillée.

L'EBIT par action mesure le bénéfice opérationnel attribué à chaque action en circulation.

Accéder à ces données via l’API Eulerpool

100 000 requêtes/mois gratuites · sans carte bancaire

Compte de résultat — Genomic Valley Biotech

Toutes les Métriques Clés — Genomic Valley Biotech

Croissance